These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35137541)

  • 1. Recruitment of IL-1β-producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion.
    Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Li X; Feng J
    Thorac Cancer; 2022 Mar; 13(6):811-823. PubMed ID: 35137541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxins Enhance Recruitment of Nonclassical Monocytes via Chemokines Produced by Pleural Mesothelial Cells in Tuberculous Pleural Effusion.
    Luo L; Li X; Hu X; Hu C; Tang W; Deng S; Feng J
    Am J Respir Cell Mol Biol; 2019 Apr; 60(4):454-464. PubMed ID: 30422670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
    Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
    J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5a enhances inflammation and chemotaxis of γδ T cells in malignant pleural effusion.
    Deng S; Jiang Y; Luo L; Tang H; Hu X; Wu C; Tang J; Ge H; Gong X; Cai R; Wang G; Li X; Feng J
    Int Immunopharmacol; 2024 Jan; 127():111332. PubMed ID: 38071913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].
    Chen L; Zhou Q; Zhong F; Wang Q; Fang Y; Yang K; Guan S
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):823-7. PubMed ID: 25620478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylatoxins orchestrate Th17 response via interactions between CD16+ monocytes and pleural mesothelial cells in tuberculous pleural effusion.
    Deng S; Hu X; Luo L; Tang W; Jiang Y; Yin F; Hu C; Feng J; Li X
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009508. PubMed ID: 34237073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion.
    Chang YM; Huang WY; Yang SH; Jan CI; Nieh S; Lin YS; Chen SF; Lin YC
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells mediate malignant pleural effusion formation.
    Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
    J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
    Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
    Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
    Front Immunol; 2021; 12():760683. PubMed ID: 34966384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
    Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
    Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
    Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
    Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
    Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.
    Stathopoulos GT; Sherrill TP; Karabela SP; Goleniewska K; Kalomenidis I; Roussos C; Fingleton B; Yull FE; Peebles RS; Blackwell TS
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1273-81. PubMed ID: 20595227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High IL-35 pleural expression in patients with tuberculous pleural effusion.
    Dong X; Yang J
    Med Sci Monit; 2015 May; 21():1261-8. PubMed ID: 25935866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.